Emerging evidence links galectin-3 with systemic proinflammatory-profibrotic responses in conditions such as aortic stenosis and diabetes, suggesting its role in myocardial remodeling and prognosis [10]. This evidence concerns the gene LGALS3 and diabetes mellitus.